Author:
Anastassakis Konstantinos
Publisher
Springer International Publishing
Reference216 articles.
1. McConnell JD. The pathophysiology of benign prostatic hyperplasia. J Androl. 1991;12(6):356–63.
2. Stamatiou K. Management of benign prostatic hypertrophy-related urinary retention: current trends and perspectives. Urol J. 2009 Fall;6(4):237–44.
3. Vaughan D, Imperato-McGinley J, McConnell J, et al. Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology. 2002;60(6):1040–4.
4. Andersen JT, Nickel JC, Marshall VR, Schulman CC, Boyle P. Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. Urology. 1997;49(6):839–45.
5. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186(4170):1213–5.